Angiotensin-Converting Enzyme Inhibitors an Angiotensin II-Receptor Antagonists

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Seminars in Cardiothoracic and Vascular Anesthesia

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/108925329800200305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose.

  1997cited by this paper
• Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.

  1996cited by this paper
• Kinins in the cardiovascular system.

  1996cited by this paper
• Adverse Effects of the Angiotensin-Converting Enzyme Inhibitors

  1996cited by this paper
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.

  1995cited by this paper
• Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension

  1995cited by this paper
• Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors.

  1995cited by this paper
• A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.

  1995cited by this paper
• Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme

  1995cited by this paper
• Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension

  1995cited by this paper
• Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.

  1995cited by this paper
• Blockade of the renin-angiotensin system.

  1994cited by this paper
• Angiotensin‐Converting Enzyme Inhibitors and Cough: A Prospective Evaluation in Hypertension and in Congestive Heart Failure

  1994cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

  1993cited by this paper
• Role of angiotensin in the extravascular system.

  1993cited by this paper
• Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.

  1993cited by this paper
• Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.

  1993cited by this paper
• Localization of components of the renin-angiotensin system and site of action of inhibitors.

  1993cited by this paper
• Cough and inhibition of the renin-angiotensin system.

  1993cited by this paper
• Psychiatric and otologic diagnoses in patients complaining of dizziness.

  1993cited by this paper
• Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.

  1993cited by this paper
• Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.

  1993cited by this paper
• Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis

  1993cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group.

  1992cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure

  1992cited by this paper
• Quality of life in treatment of hypertension. A metaanalysis of clinical trials.

  1992cited by this paper
• The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

  1992cited by this paper
• Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.

  1992cited by this paper
• Identification of two subtypes in the rat type I angiotensin II receptor

  1992cited by this paper
• Angiotensin II receptors and functional correlates.

  1992cited by this paper
• Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.

  1992cited by this paper
• Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.

  1992cited by this paper
• Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.

  1991cited by this paper
• Angiotensin-(1-7): a new hormone of the angiotensin system.

  1991cited by this paper
• Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence

  1991cited by this paper
• Changes in expression of angiotensin receptor subtypes in the rat aorta during development.

  1991cited by this paper
• Dose-response relationships following oral administration of DuP 753 to normal humans.

  1991cited by this paper
• Effect of the Renin Response During Renin Inhibition: Oral Ro 42–5892 in Normal Humans

  1991cited by this paper
• Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.

  1991cited by this paper
• Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

  1991cited by this paper
• Blood pressure control--special role of the kidneys and body fluids.

  1991cited by this paper
• Molecular forms of human IGF binding proteins: physiological implications.

  1991cited by this paper
• Subtype 2 Angiotensin Receptors Mediate Prostaglandin Synthesis in Human Astrocytes

  1991cited by this paper
• Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine.

  1990cited by this paper
• The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.

  1990cited by this paper
• Central and Peripheral Actions of a Nonpeptidic Angiotensin II Receptor Antagonist

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists.

  1990cited by this paper
• Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema.

  1990cited by this paper
• The angiotensin II receptor and the actions of angiotensin II.

  1990cited by this paper
• The Treatment of Moderate to Severe Hypertension with ACE Inhibitors

  1990cited by this paper
• Tissue Renin-Angiotensin Systems in the Pathophysiology of Heart Failure

  1990cited by this paper
• Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

  1990cited by this paper
• Preliminary biochemical characterization of two angiotensin II receptor subtypes.

  1989cited by this paper
• Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.

  1989cited by this paper
• Identification of angiotensin II receptor subtypes.

  1989cited by this paper
• Tissue plasminogen activator.

  1988cited by this paper
• Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

  1988cited by this paper
• Angiotensin-converting enzyme and the cough reflex.

  1987cited by this paper
• Circulating and tissue angiotensin systems.

  1987cited by this paper
• Increased Survival in Rats with Congestive Heart Failure Treated with Enalapril

  1987cited by this paper
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

  1987cited by this paper
• The renin-angiotensin system

  1987cited by this paper
• The Unusual Substrate Specificity and the Distribution of Human Angiotensin I Converting Enzyme Special Lecture

  1986cited by this paper
• Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat.

  1985cited by this paper
• Effects of angiotensin converting enzyme inhibition: a clinical point of view.

  1985cited by this paper
• Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

  1984cited by this paper
• Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall.

  1984cited by this paper
• The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G.

  1982cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper
• Hemodynamic Effects of Exogenous and Endogenous Vasopressin at Low Plasma Concentrations in Conscious Dogs

  1980cited by this paper
• Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.

  1979cited by this paper
• Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

  1978cited by this paper
• Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

  1978cited by this paper
• Lowering of hypertension by central saralasin in the absence of plasma renin

  1977cited by this paper
• Renin-angiotensin system: biochemistry and mechanisms of action.

  1977cited by this paper
• Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

  1977cited by this paper
• The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.

  1976cited by this paper
• Angiotensin I converting enzyme.

  1975cited by this paper
• Effects of Angiotensin II on DNA, RNA and Protein Synthesis

  1972cited by this paper
• Role of the Pressor Action of Angiotensin IIin Experimental Hypertension

  1971cited by this paper
• Renin secretion in renal hypertension.

  1970cited by this paper
• A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.

  1970cited by this paper
• The regulation of aldosterone secretion by the renin-angiotensin system under various conditions.

  1967cited by this paper
• Bradykinin: Vascular Relaxant, Cardiac Stimulant

  1963cited by this paper
• THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME

  1956cited by this paper
• STUDIES ON EXPERIMENTAL HYPERTENSION

  1934cited by this paper
• Niere und Kreislauf1

  year unknowncited by this paper

• No citing papers are available for this paper.